TABLE OF CONTENTS
Volume 26, Issue 3 (18 January 2007)
Original Articles
Compensation and specificity of function within the E2F family
L-J Kong, J T Chang, A H Bild and J R Nevins
Oncogene 26: 321-327; advance online publication, August 14, 2006; doi:10.1038/sj.onc.1209817
Single-stranded RNA viruses inactivate the transcriptional activity of p53 but induce NOXA-dependent apoptosis via post-translational modifications of IRF-1, IRF-3 and CREB
C Lallemand, B Blanchard, M Palmieri, P Lebon, E May and M G Tovey
Oncogene 26: 328-338; advance online publication, July 10, 2006; doi:10.1038/sj.onc.1209795
Pre-B-cell leukemia transcription factor 1 is a major target of promyelocytic leukemia zinc-finger-mediated melanoma cell growth suppression
K Shiraishi, K Yamasaki, D Nanba, H Inoue, Y Hanakawa, Y Shirakata, K Hashimoto and S Higashiyama
Oncogene 26: 339-348; advance online publication, July 24, 2006; doi:10.1038/sj.onc.1209800
Reg I-knockout mice reveal its role in regulation of cell growth that is required in generation and maintenance of the villous structure of small intestine
T Ose, Y Kadowaki, H Fukuhara, H Kazumori, S Ishihara, J Udagawa, H Otani, S Takasawa, H Okamoto and Y Kinoshita
Oncogene 26: 349-359; advance online publication, August 14, 2006; doi:10.1038/sj.onc.1209799
Decreased survival of C/EBP
-deficient keratinocytes is due to aberrant regulation of p53 levels and function
K Yoon, S Zhu, S J Ewing and R C Smart
Oncogene 26: 360-367; advance online publication, July 10, 2006; doi:10.1038/sj.onc.1209797
A soluble ectodomain of LRIG1 inhibits cancer cell growth by attenuating basal and ligand-dependent EGFR activity
S Goldoni, R A Iozzo, P Kay, S Campbell, A McQuillan, C Agnew, J-X Zhu, D R Keene, C C Reed and R V Iozzo
Oncogene 26: 368-381; advance online publication, July 17, 2006; doi:10.1038/sj.onc.1209803
Cooperation between Myc and YY1 provides novel silencing transcriptional targets of 
31-integrin in tumour cells
F de Nigris, C Botti, R Rossiello, E Crimi, V Sica and C Napoli
Oncogene 26: 382-394; advance online publication, July 31, 2006; doi:10.1038/sj.onc.1209804
Regulation of the Ets-1 transcription factor by sumoylation and ubiquitinylation
Z Ji, C Degerny, N Vintonenko, J Deheuninck, B Foveau, C Leroy, J Coll, D Tulasne, J-L Baert and V Fafeur
Oncogene 26: 395-406; advance online publication, July 24, 2006; doi:10.1038/sj.onc.1209789
Phorbol 12-myristate 13-acetate and serum synergize to promote rapamycin-insensitive cell proliferation via protein kinase C-eta
P M Martin, S E Aeder, C A Chrestensen, T W Sturgill and I M Hussaini
Oncogene 26: 407-414; advance online publication, July 10, 2006; doi:10.1038/sj.onc.1209791
The 26S proteasome system degrades the ERM transcription factor and regulates its transcription-enhancing activity
J-L Baert, C Beaudoin, D Monte, C Degerny, S Mauen and Y de Launoit
Oncogene 26: 415-424; advance online publication, July 10, 2006; doi:10.1038/sj.onc.1209801
Annexin II binds progastrin and gastrin-like peptides, and mediates growth factor effects of autocrine and exogenous gastrins on colon cancer and intestinal epithelial cells
P Singh, H Wu, C Clark and A Owlia
Oncogene 26: 425-440; advance online publication, July 10, 2006; doi:10.1038/sj.onc.1209798
E2A protein degradation by the ubiquitin-proteasome system is stage-dependent during muscle differentiation
L Sun, J S Trausch-Azar, A Ciechanover and A L Schwartz
Oncogene 26: 441-448; advance online publication, August 7, 2006; doi:10.1038/sj.onc.1209793
Short Communications
The Ras-MAPK pathway downregulates Caveolin-1 in rodent fibroblast but not in human fibroblasts: implications in the resistance to oncogene-mediated transformation
K Sasai, K Kakumoto, H Hanafusa and T Akagi
Oncogene 26: 449-455; advance online publication, July 10, 2006; doi:10.1038/sj.onc.1209792
KLF8 transcription factor participates in oncogenic transformation
X Wang and J Zhao
Oncogene 26: 456-461; advance online publication, July 10, 2006; doi:10.1038/sj.onc.1209796
A constitutively active ERBB4/HER4 allele with enhanced transcriptional coactivation and cell-killing activities
G A Vidal, D E Clark, L Marrero and F E Jones
Oncogene 26: 462-466; advance online publication, July 10, 2006; doi:10.1038/sj.onc.1209794
Oncogenomics
DSG3 is overexpressed in head neck cancer and is a potential molecular target for inhibition of oncogenesis
Y-J Chen, J T Chang, L Lee, H-M Wang, C-T Liao, C-C Chiu, P-J Chen and A-J Cheng
Oncogene 26: 467-476; advance online publication, July 31, 2006; doi:10.1038/sj.onc.1209802
